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Abstract: We report on a label-free immunosensor based on graphene field effect transistors (G-FETs)
for the ultrasensitive detection of Human Chorionic Gonadotrophin (hCG), as an indicator of
pregnancy and related disorders, such as actopic pregnancy, choriocarcinoma and orchic teratoma.
Pyrene based bioactive ester was non-covalently anchored onto the graphene channel in order to
retain the sp2 lattice. The G-FET transfer characteristics showed repeatable and reliable responses
in all surface modifying steps using a direct current (DC) readout system. The hCG concentration
gradient showed a detection limit of ~1 pg·mL−1. The proposed method facilitates the cost-effective
and viable production of graphene point-of-care devices for clinical diagnosis.
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1. Introduction
Human Chorionic Gonadotrophin (hCG) is a glycosylated protein (37.5 kDa) secreted by
placenta during pregnancy or gestational trophoblastic diseases [1,2]. The function of hCG is to
stimulate steroid hormone and progesterone production in the corpus luteum to support placental
growth [3]. Hence, increased levels of hCG in the serum and urine are key indicators of trophoblastic
tumors and other pregnancy related diseases [4–6]. As a result, it is significantly important to
develop a highly selective and sensitive sensor to detect hCG for early diagnosis. At present,
the detection methods for hCG mainly include various immunoassay based on electrochemical,
electrochemiluminescence, fluorescence, enzyme, chemiluminescence resonance energy transfer,
chemiluminescence and radiation [7]. Though these systems are sensitive and selective, but they
tend to be expensive, time-consuming, labor intensive, bulky and require additional electrical system
to translate into electrical signals. Hence, there is a need in manufacturing reliable and scalable
electrical method to meet the demand for point of care testing (POCT) devices.
Since the first report by Bergveld et al. on FET based immunosensor (immunoFET),
numerous studies have been conducted on immunoFET based on silicon nanowires (SiNW),
SiO2 nanobelt, ZnO nanofilm, Au nanoparticles, molybdenum disulphide (MoS2), cerium oxide (CeOx)
and single-walled carbon nanotubes (SWCNT) to name a few [8,9]. Recently, graphene attracted much
interest by various research groups to focus on the possibility of graphene based FET (gFET) due
to its unique characteristics regarding high surface to volume ratio, biocompatibility consisting of
extreme sensitivity to the environment and ambipolar behavior [10–13]. Half a dozen of reports has
appeared in last few years on back-gated graphene field effect transistor (BG-gFET) immunosensors,
indicating that there is a growing interest from both academic and industrial researchers to meet all
the challenges for cost-effective, easy to fabricate, scalable, reliable, ultrasensitive and rapid on-site
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detection devices [14–19]. Note that a non-covalent functionalization is of graphene is of much
importance as covalent functionalization augments carrier scattering instigated by the conversion of
planar sp2 to tetrahedral sp3 carbons leading to charge impurities and vacancy defects. To the best
of our knowledge, there is only one report on BG-gFET based immunoassay for hCG detection,
using multilayer epitaxial graphene grown on silicon carbide and a covalent functionalization method
was used to anchor the necessary biomolecules. Other BG-gFET based immunoassays adopted
intermediary modification of graphene either by hexamethyldisilazane (HMDS) or reduced to graphene
oxide targeting rotavirus, DNA or cancer biomarkers [15–17].
In the present study, we demonstrate a scalable CVD grown monolayer graphene based FET
immunosensor on a SiO2/Si substrate. A non-covalent bond between monolayer graphene and antibody
was facilitated by applying a linker molecule known as 1-pyrenebutyric acid–N-hydroxysuccinimide
ester (Pyr-NHS) via pi-pi bonding. The performance of the device was assessed under ambient
conditions for over 10 devices to establish higher stability and repeatability. Changes in resistance
difference between consecutive surface modifications displayed a distinctive pattern not commonly
seen in relation to the usual increase in resistance owing to biomolecular absorption. The sensor
exhibited an ultralow label-free detection limit of 1 pg·mL−1 with high sensitivity (0.30 Ω·ng−1·mL−1)
and reproducibility (>87% yield). An in-depth analysis on carrier transfer for each surface modification
was carried out for the first time for non-covalently functionalized BG-gFET illustrating the importance
of net charge, amino acid content and the isoelectric point of biomolecules. These key factors are vital
for bioelectronic sensing mechanism and device performance. The rapid, sensitive, selective, stable,
repeatable and reliable detection suggests promising applications of bgFET structure for multiple
marker detection on a point-of-care device.
2. Materials and Methods
2.1. Materials
Monolayer CVD graphene on Cu foil was purchased from Graphene Supermarket (Calverton, NY,
USA). Photoresist 1805 G2, lift-off resist 3B (LoR) and their corresponding developer and remover were
purchased from A-Gas Electronic Materials (Warwickshire, UK). All the other chemicals, such as
Pyr-NHS, iron nitride, nitric acid, PBS, Poly (methyl methacrylate) (PMMA), Ethanolamine etc.
at biochemical grade were purchased from Sigma Aldrich (Dorset, UK). Bovine serum albumin (BSA) at
biochemical grade was purchased from Sigma Aldrich (Dorset, UK). 100 µg·hCG (ab126652) lyophilized
powder and 1 mL of 0.02 mg·mL−1 complementary anti-hCG (ab8466) in PBS buffer were purchased
from Abcam (Cambridge, UK) and the prepared aliquots were stored at −20 ◦C.
2.2. Characterization of BG-gFET
Raman spectra was collected in an XploRA Raman system (Horiba, Middlesex, UK) running a
LabSpec 6.4.2.5 and equipped with a 532 nm HeNe laser delivering 20 mW of laser power at the sample.
An Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) with a 100 µm slit width, a 300 µm
confocal hole, 1200 T grating and 1000× magnification was used. An MPlan N 100× microscope
objective (N.A.: 0.90, W.D.: 0.21, F.N.: 22) focused the laser on the sample into a spot of ~7.45 µm
diameter. A thermoelectrically cooled charge coupled device (CCD) camera was used for detection.
Single spectra were collected for bare, coated and non-coated dentine by graphene from 1100 cm−1 to
3000 cm−1 range with five accumulations each lasting 15 s.
X-ray photoelectron spectroscopy (XPS) was performed with Kratos AXISULTRA with a mono-
chromated Al kα X-ray source (1486.6 eV) using an emission current of 10 mA and an anode potential
of 12 kV (120 W). The ULTRA was used in fixed analyzer transmission (FAT) mode, with pass energy
of 80 eV for wide scans and pass energy 20 eV for high resolution scans. Cyclic Voltammetry (CV)
measurements were carried out in 10 mM ferricyanide aqueous solution (1 M KCl solution) at room
temperature with a scan potential range from 0.8 V to −0.4 V and a scan rate of 100 mV·s−1.
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2.3. Sensor Test and Data Analysis
A Keysight B1500A semiconductor device parameter analyzer with an MPS150 probe station
(Cascade Microtech GmbH, Thiendorf, Germany) was employed to investigate the electrical
characteristics and sensing performance of the FET device at room temperature. The transistor
measurement on the sensor was carried out by measuring the drain current (Ids) as a function of
the gate voltage (Vg) (−100 V to +100 V) with a fixed drain-source voltage (Vds = 100 mV). The sensing
signal of the device was recorded by monitoring the Ids as a function of drain-source voltage (Vd) (−1 V
to +1 V) with a fixed gate voltage (Vds = 0 V). The data were analysed using SigmaPlot 13 software
(Systat Software Inc, London, UK).
2.4. Wet Transfer of Graphene
The monolayer graphene was obtained from Graphene Supermarket (Calverton, NY, USA),
and it was synthesized on both sides of 25 µm thick copper foil through chemical vapour deposition
(CVD) method [20]. The wet transfer process as shown in Figure 1 was used to transfer monolayer
graphene onto SiO2/Si substrates as follows. Firstly, PMMA was dissolved in the chlorobenzene with
a 10 mg·mL−1 concentration and spin-coated on the one side of the graphene film at a spin speed of
4000 rpm for 30 s followed by baking at 180 ◦C for 1 min. To etch the Cu substrate, 10% HNO3 was used
for 2 min followed by etching in 0.1 M ammonium persulfate for approximately 3 h with the endpoint
determined when Cu was no longer visible. The resulted PMMA/graphene membrane was transferred
to a rinse bath of deionized (DI)water for 10 min. Subsequently, monolayer graphene was directly
transferred onto SiO2/Si substrates. Finally, PMMA layer was removed by acetone treatment at 50 ◦C
for five minutes following by cleaning with Isopropyl alcohol (IPA) and DI water. Graphene on SiO2/Si
substrates obtained as such was dried in vacuum before characterization and measurements.
Figure 1. Schematic illustration of graphene wet transfer on SiO2/Si. The process begins with
a graphene monolayer on Cu foil (a); After depositing a support layer composed of PMMA (b);
the bottom graphene layer and Cu layer are etched by floating the sample on a HNO3 and (NH4)2S2O8
respectively (c,d); After transferring the resulting graphene-PMMA bilayer on a SiO2/Si substrate,
PMMA removal by acetone (e,f) completes the transfer process.
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2.5. Materials Fabrication of hCG Biosensor
A schematic illustration of the fabrication of hCG biosensor is shown in Figure 2. A flexible
monolayer-layer graphene film on SiO2/Si substrate was obtained by wet-transfer method as
mentioned above [21,22]. In order to fabricate source-drain and voltage electrodes, two consecutive
photolithography was conducted. The lithography process begins with spin-coating LoR and positive
photoresist (pPR) at 3000 rpm for 30 s. LoR was pre-baked at 175 ◦C for 15 min followed by soft-baking
of spin-coated pPR at 100 ◦C for 1 min. For shaping graphene channel, samples were hard-baked
at 180 ◦C for about an hour under deep UV (DUV) to reduce the pPR effect on graphene channel as
much as possible [19]. We used a modified Argon plasma method to sputter the graphene on SiO2/Si
at 50 W and 6 × 10−7 Torr for 2 min [23]. We deposited 5 nm Cr puddles for contact by thermal
evaporator followed by 30 nm of Au layer by sputtering at 2 × 10−7 Torr and 4 mTorr base and Ar
pressure [24]. The thickness of SiO2 is 300 nm and the width and length of each FET unit is 90 µm and
80 µm respectively.
Figure 2. Schematic illustration of hCG biosensor fabrication. (a) monolayer graphene on SiO2/Si substrate;
(b) Fabrication of BG-gFET; (c) anchoring of non-covalent linkers by pi-pi bond; (d) immobilization of
antibodies; (e) blocking by BSA; (f) binding of hCG antigen.
Pyr-NHS was used as the linker between graphene channel and anti-hCG via pi-pi interaction.
Consisting of hydrophobic pyrenyl moiety base and a bio-active ester head, Pyr-NHS does not require
any pre-treatment of antigen with EDAC/NHS chemistry is required [14]. 2 mM Pyr-NHS solution
was prepared by adding 0.0385 g Pyr-NHS powder into 5 mL methanol with modest shaking for 5 h.
The linker solution was drop-casted on BG-gFETs and sealed in a moist environment for 2 h at room
temperature, followed by methanol rinsing to avoid passivation layer formation. The functionalized
graphene channels were covered by 10 µg·mL−1 anti-hCG solution and incubated at 4 ◦C for 4 h.
The surface of graphene channel was rinsed with PBS buffer and immersed in BSA solution with
a concentration of 0.5 mg·mL−1 to block the free amino groups to prevent the non-specific binding
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of hCG. Finally, hCG solution with concentrations ranging from 1 pg·mL−1 to 100 ng·mL−1 were
prepared by diluting 1 µg·mL−1 stock solution with PBS buffer and then incubated on graphene
channel at 4 ◦C for 4 h to ensure the strong antibody/antigen binding. Finally, the samples were
treated with 100 mM ethnolamine for 30 min and washed with DIW for 5 min to remove non-specific
passivation followed by vacuum dry at 30 Torr for an hour before characterization [25].
3. Results and Discussion
3.1. Assessment of Surface Morphology
The morphology of the samples and surface modification was characterized by Raman
spectroscopy, XPS and cyclic voltammetry. Figure 3 shows raman maps of 2D/G for graphene/SiO2
before and after adding linker and others. The intensity ratios of 2D-band to G-band are higher
than 5. These data confirm that the transferred graphene before and after treating with linker
and others is high-quality and continuous. For effective removal of photoresist during fabrication,
deep UV (DUV) technique was used within the fabrication process to reduce photoresist contamination.
The details of our work to obtain clean, uniform, and continuous graphene, with a typical low sheet
resistance along with XPS and Cyclic voltammetry analysis have been elaborated in our recent works
in detail [19,23]. The results demonstrated effective reduction of sheet resistance and contact resistance
on the graphene surface by about 60% and 80%, respectively. Electrical current transport characteristics
also demonstrated minimizing this residue on the graphene surface giving less hysteresis of electronic
transport in BG-gFETs.
Figure 3. Raman maps of 2D/G for (a) bare graphene/SiO2; (b) linker + graphene/SiO2; (c) anti-hCG
+ linker/graphene/SiO2; (d) hCG + anti-hCG/linker/graphene/SiO2.
3.2. Qualitavie Assessment of Graphene and Surface Modification
Raman spectroscopy was used to confirm the layer number of graphene film. In the Raman
spectrum shown in Figure 4a, the G-peak (~1600 cm−1) and 2D-peak (~2700 cm−1) are clearly
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resolved with strong intensity and sharp shape of 2D peak, indicating that the graphene film
is monolayer. To avoid possible surface contaminations, all devices were thermal-annealed (Ar
1.5 ccm and H2 250 sccm, 300 K) before electrical measurements were performed. Figure 4b
presents the back gate (Vback·gate)-dependent resistance measurement results of a typical graphene
FET device, showing the ambipolar field-effect characteristics. Both the carrier type and density of
graphene can be modulated by Vback·gate. The maximum resistance (or the minimal conductance)
point corresponds to the charge neutrality point Vcnp (or the Dirac point in the case of monolayer
graphene), indicating how the graphene film is intrinsically doped, i.e., p/n doped when Vcnp is
positive/negative or non-doped when Vcnp is equal to zero. For this particular device, Vcnp is
around 12 V, suggesting it is intrinsically p-doped. The p-doping characteristics of graphene are
usually caused by exposure to an oxygen-containing atmosphere, as oxygen molecules adsorbed onto
defect or oxidized sites on a graphene surface will function as p-type dopants by trapping electrons
during device fabrication process [26]. Several studies have shown that the conductance of graphene
device exhibited ambipolar behavior and demonstrated better operating stability and higher sensing
performance in the p-type region than in the n-type region [27,28]. The slight asymmetry around
the Dirac point can be ascribed to the interaction of graphene with the contacts, as explained by
Di Bartolomeo et al. [29,30].The feature of being sensitive to the surrounding environment renders
graphene an ideal sensing material for detecting charged objects. With the presence of certain charged
environment, the charge doping level (or Fermi level) of graphene will be changed, resulting in a shift
of Vcnp or the resistance-Vback·gate curve.
Figure 4. Raman characterization of patterned graphene channel (a) and resistance-back gate voltage
curve of a typical graphene FET device (b).
3.3. Dependence of hCG Concentration
To examine the performance of bgFET immunosensor for detection, we performed a quantitative
analysis on multiple BG-gFET devices to examine the change in resistance of the graphene channel
after Ab-hCG binding ranging from 1 pg·mL−1 to 100 ng·mL−1. All the devices were formed
by modification processes under controlled physiochemical conditions. We used 100 µg·L−1 PBS
to obtain standard solutions with different concentrations. After adding standard solutions with
different concentrations for four hours at 4 ◦C followed by washing with PBS and N2 drying,
we measured the resistance-Vback·gate curves within 2 min. The pH of standard solutions was kept
at neutral to avoid false response. At least three replicates were conducted for each concentration
and the relative standard deviations between replicates were 5–24%, indicating good reproducibility
Biosensors 2017, 7, 27 7 of 10
of our measurement. The test results of standard solutions with five concentrations (i.e., 1 pg·mL−1,
10 pg·mL−1, 100 pg·mL−1, 1 ng·mL−1, 100 ng·mL−1) are shown in Figure 5a. Before adding solutions,
the Vcnp was around 12 V, indicating the p-doping nature of the device in dry state. After adding
standard solution of 1 pg·mL−1, we clearly observed right shifts of the curve, i.e., higher Vcnp.
For higher concentrations, the resistance-Vback·gate shifted further right and Vcnp became higher.
Figure 5. (a) The resistance-Vback·gate curves of five different hCG concentrations (1 pg·mL−1~100 ng·mL−1).
(b) The measured ∆Vcnp versus concentration (in semilog scale); The red dotted line corresponds to
the fitting results by using a four parameter logistic function.
Such results indicate that our bgFET immunosensors are effective for detecting at different
concentrations. The detection mechanism can be explained by a simple picture that, in dry condition,
higher concentrations of hCG cause electron doping of the graphene (which is intrinsically p-doped)
by approaching its surface, which leads to a right shift of the transfer curves or a higher Vcnp [31] and
potentially used as an effective parameter to characterize ion concentrations. We tested multiple
devices with similar response observed. In Figure 5b, we plotted the measured ∆Vcnp versus
concentration (in logarithmic scale) of the tested standard solutions from three representative devices.
A lognormal fitting was performed to obtain a calibration curve for quantification. Based on
our measurement, the lowest concentration our graphene aptasensor detected was 1 pg·mL−1,
and a concentration-response calibration curve showed a good fitting (R2 = 0.97) in the range of
concentration evaluated, which is advantageous for the detection of hCG having wide-ranging
expression profiles in the different stages of diagnosis i.e., pregnancy or cancer development.
The obtained limit of detection (LOD) was 600 times more sensitive than the one achieved with
the previously published hCG biosensor on BG-gFET [15] and twenty times better than one obtained
with polysilicon nanogap [32]. In addition, our biosensor was capable of clearly monitoring
the anti-hCG + hCG interaction at concentration as low as 1 pg·mL−1 directly without pre- or
post-amplification process. This demonstrated that our aptasensor can work well for samples much
lower than the safe level.
3.4. Slectivity, Stability, Reproducibility and Reusability
Selectivity tests were carried out by using interfering species, such as BSA, glucose, uric acid (UA),
ascorbic acid (AA) and 1 pg/mL of hCG (Figure 6a). It can be observed that the response of
interfering species on our BG-gFET is less than 40 mV at the lowest concentration of hCG. In addition,
the BG-gFETs showed satisfactory stability. After a month long storage, the resistance response
decreased 21%, which is due to the gradual deactivation of the immobilized biomolecules (Figure 6b).
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At present, the sensor is for one-time use only, however, to extend the BG-gFET sensor into practical
reusable applications, further work is needed.
Figure 6. Selectivity and stability measurements for BG-gFET immunosensor. (a) The selectivity of
the immunosensor with interfering species. BSA, Glucose (GLUC), Uric Acid (UA) and Ascorbic
Acid (AA) were used; (b) long term stability of the biosensor for upto four weeks of storage.
4. Conclusions
In summary, we demonstrated a BG-gFET based immunosensor functionalized with a non-
covalent linker for high sensitivity and label-free detection of hCG. The sensors showed the detection
of hCG at concentration levels as low as 1 pg·mL−1, which is much lower than the clinical limit
(5 ng·mL−1) with a broad dynamic range in concentration (1 pg·mL−1 to 100 ng·mL−1) [15]. Further
development in multiple markers with a multiplex array is necessary for scalable and cost-effective
detection. These results clearly show that BG-gFET immunosensors are promising devices for the use
as label-free biological sensors that can electrically detect biomolecules.
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